Author details

Full Name

Alvin Farrel

Affiliation

Children's Hospital of Philadelphia

ORCID

Career Start Year

2008

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37292750	Structural principles of peptide-centric Chimeric Antigen Receptor recognition guide therapeutic expansion.	bioRxiv	2023
37516886	ROGUE: an R Shiny app for RNA sequencing analysis and biomarker discovery.	BMC Bioinformatics	2023
37938771	Targeting of intracellular oncoproteins with peptide-centric CARs.	Nature	2023
38039376	Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion.	Sci Immunol	2023
36381237	Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma.	Cancer Res Commun	2022
36396952	Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma.	Commun Biol	2022
34732890	Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.	Nature	2021
34893640	Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction.	Nat Commun	2021
34469647	Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells.	N Engl J Med	2021
32511347	A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity.	bioRxiv	2020
32835302	Identification of SARS-CoV-2 Vaccine Epitopes Predicted to Induce Long-Term Population-Scale Immunity.	Cell Rep Med	2020
32714112	A SARS-CoV-2 Vaccination Strategy Focused on Population-Scale Immunity.	SSRN	2020
32307821	Limited antitumor activity of combined BET and MEK inhibition in neuroblastoma.	Pediatr Blood Cancer	2020
32256484	Immunogenicity and Immune Silence in Human Cancer.	Front Immunol	2020
31693904	Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.	Cell Rep	2019
31672841	YAP1 Mediates Resistance to MEK1/2 Inhibition in Neuroblastomas with Hyperactivated RAS Signaling.	Cancer Res	2019
31810498	Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition.	J Immunother Cancer	2019
28839204	Effects of short indels on protein structure and function in human genomes.	Sci Rep	2017
28715997	An efficient algorithm for improving structure-based prediction of transcription factor binding sites.	BMC Bioinformatics	2017
27307632	Structure-based prediction of transcription factor binding specificity using an integrative energy function.	Bioinformatics	2016
19607800	Characterization of DNA glycosylase activity by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.	Anal Biochem	2009
18485883	Characterization of synthetic oligonucleotides containing biologically important modified bases by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.	Anal Biochem	2008

1 - 22 of 22

Tao Wang

University of Texas Southwestern Medical Center

Career Start Year 2014

Number of shared co-authors 0

Michael T Zimmermann

Medical College of Wisconsin

Career Start Year 2009

Number of shared co-authors 3

Daizhan Zhou

The Fourth Affiliated Hospital, Zhejiang University School of Medicine

Career Start Year 2008

Number of shared co-authors 0

Hannah Carter

University of California San Diego

Career Start Year 2008

Number of shared co-authors 0

Eric Paquet

University of Laval

Career Start Year 2007

Number of shared co-authors 0

Raul Rabadan

Columbia University Vagelos College of Physicians and Surgeons

Career Start Year 2006

Number of shared co-authors 3

Xiaotu Ma

St. Jude Children's Research Hospital

Career Start Year 2006

Number of shared co-authors 7

Yue Lu

The University of Texas MD Anderson Cancer Center

Career Start Year 2006

Number of shared co-authors 1

Semin Lee

Ulsan National Institute of Science and Technology (UNIST)

Career Start Year 2005

Number of shared co-authors 6

Milana Frenkel-Morgenstern

Bar-Ilan University

Career Start Year 2005

Number of shared co-authors 0

Elena Zaslavsky

Icahn School of Medicine at Mount Sinai

Career Start Year 2004

Number of shared co-authors 1

Malachi Griffith

Washington University

Career Start Year 2003

Number of shared co-authors 1

Andrew V Kossenkov

The Wistar Institute

Career Start Year 2003

Number of shared co-authors 1

Olivier Elemento

Meyer Cancer Center

Career Start Year 2002

Number of shared co-authors 1

Osvaldo Gra??a

Spanish National Cancer Research Centre-CNIO

Career Start Year 2002

Number of shared co-authors 1

Ludmila Danilova

Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine

Career Start Year 2001

Number of shared co-authors 3

Vladimir Makarov

Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic

Career Start Year 2001

Number of shared co-authors 0

Yan W Asmann

Mayo Clinic

Career Start Year 2000

Number of shared co-authors 0

Wei Wang

IBM Thomas J Watson Research Center, University of California Los Angeles, University of North Carolina at Chapel Hill

Career Start Year 1999

Number of shared co-authors 0

Shawn Levy

HudsonAlpha Institute for Biotechnology

Career Start Year 1999

Number of shared co-authors 0

Alex Kentsis

Memorial Sloan-Kettering Cancer Center

Career Start Year 1998

Number of shared co-authors 0

Daron M Standley

Osaka university

Career Start Year 1998

Number of shared co-authors 0

Sarah J Wheelan

National Human Genome Research Institute, National Institutes of Health

Career Start Year 1998

Number of shared co-authors 0

Shannon K McWeeney

Oregon Health & Science University, University of California Berkeley

Career Start Year 1997

Number of shared co-authors 1

Robert A Holt

BC Cancer Research Institute

Career Start Year 1996

Number of shared co-authors 8

Panayiotis V Benos

University of Florida

Career Start Year 1996

Number of shared co-authors 0

Steven J M Jones

University of British Columbia

Career Start Year 1995

Number of shared co-authors 15

Zhiping Weng

University of Massachusetts Medical School

Career Start Year 1992

Number of shared co-authors 2

Richard H Scheuermann

J. Craig Venter Institute

Career Start Year 1983

Number of shared co-authors 0

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 8

row(s) 1 - 30 of 30